<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention — IARC Working Group Report

Jin Young Park

International Agency for Research on Cancer, Early Detection, Prevention, and Infections Branch, Lyon, France

Yi-Chia Lee

Departments of Medical Research and Internal Medicine, National Taiwan University Hospital, Taipei

Paul Moayyedi

Farncombe Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada

Iris Lansdorp-Vogelaar

International Agency for Research on Cancer, Early Detection, Prevention, and Infections Branch, Lyon, France

M. Constanza Camargo

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Bojan Tepeš

National Institute of Public Health, Ljubljana, Slovenia

Christian C. Abnet

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Il Ju Choi

Center for Gastric Cancer, National Cancer Center, Goyang, South Korea

Gary Clifford

International Agency for Research on Cancer, Early Detection, Prevention, and Infections Branch, Lyon, France

Mario Dinis-Ribeiro

Portuguese Institute of Oncology of Porto, Porto Comprehensive Cancer Center, Porto, Portugal

Markus Gerhard

Institute of Medical Microbiology, Immunology and Hygiene, Department of Preclinical Medicine, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany

Javier P. Gisbert

Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid

Karen J. Goodman

Department of Medicine, University of Alberta, Edmonton, Canada

Joo Ha Hwang

Manami Inoue

National Cancer Center Institute for Cancer Control, Tokyo

Violet Kayamba

University of Zambia School of Medicine, Nationalist Road, Lusaka, Zambia

Marcis Leja

Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia

Wai Keung Leung

Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong

Wen-Qing Li

State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Cancer Epidemiology, Peking University Cancer Hospital and Institute, Beijing

Peter Malfertheiner

Ludwig Maximilian University Medical Clinic II, Grosshadern, Munich, Germany

Zorana Maravic

Digestive Cancers Europe, Brussels

Tamara Matysiak-Budnik

Institut des Maladies de l’Appareil Digestif, Hepato-Gastroenterology and Digestive Oncology, Nantes University Hospital, Nantes, France

Melissa McLeod

Department of Public Health, University of Otago, Wellington, Wellington, New Zealand

Francis Megraud

INSERM Unité 1312, Bordeaux Institute of Oncology, University of Bordeaux, Bordeaux, France

Eileen Morgan

International Agency for Research on Cancer, Cancer Surveillance Branch, Lyon, France

Duco T. Mülder

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands

Julie Parsonnet

Department of Medicine and Department of Epidemiology and Population Health, Stanford University, Stanford, CA

Pempa Pempa

Ministry of Health, Thimphu, Bhutan

Guru Prasad Dhakal

Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan

Arnoldo Riquelme

Department of Gastroenterology, Faculty of Medicine, Center for Cancer Prevention and Control, Pontificia Universidad Católica de Chile, Santiago

Peter Sasieni

Stella Smith

Molecular Biology and Biotechnology Department, Nigeria Institute of Medical Research, Lagos, Nigeria

Janet Takens

Thomas More University of Applied Sciences, Malines, Belgium

Andrea Teng

Department of Public Health, University of Otago, Wellington, Wellington, New Zealand

David Forman

Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom